MSGS Madison Square Garden Sports 2026 stock outlook: owning the Knicks and Rangers, franchise value versus thin operating cash flow, Dolan family control, NBA and NHL media rights, the NAV discount, peers, and US tax angles.
VITL Vital Farms 2026 stock outlook: the pasture-raised egg and butter brand model, avian flu and egg price swings, scaling margins, the move from Whole Foods to mainstream grocery, peers like Cal-Maine, and US tax angles after a steep drawdown.
WFG West Fraser Timber 2026 stock outlook: scale in lumber and OSB, housing and repair-remodel cyclicality, US-Canada softwood duties, buybacks, peers like Weyerhaeuser and Interfor, and the US tax angle for investors.
SAH Sonic Automotive 2026 stock outlook: how fixed operations and finance and insurance profits cushion a franchised dealer group, what EchoPark's used-car losses mean, rate-cut and used-price sensitivity, peers, and tax angles for US investors.
CNXC (Concentrix) 2026 stock outlook: the post-Webhelp debt load, the guidance cut, a dividend yield near 6%, buybacks, and the real debate over whether AI shrinks or reshapes outsourced customer service. Peers, scenarios and tax angles included.
OLED (Universal Display) 2026 stock outlook: phosphorescent emitter materials, the royalty and licensing model, Samsung and LG customer concentration, the blue emitter catalyst, the patent-cliff debate, peers, and US tax angles.
AAT American Assets Trust 2026 stock outlook: West Coast retail strength, the office overhang, FFO guidance and dividend cover, the redevelopment pipeline, peer comparison, and US tax angles for income investors.
IIPR Innovative Industrial Properties 2026 stock outlook: cannabis sale-leaseback triple-net model, tenant default and concentration risk, dividend coverage, rescheduling upside, rate sensitivity, net-lease peers, and REIT tax angles for US investors.
METC (Ramaco Resources) 2026 stock outlook: low-cost Appalachian metallurgical coal, the Brook Mine rare-earth option in Wyoming, Class A and B shares, met coal price cycles, dilution risk, peers, and tax angles for US investors.
HRMY Harmony Biosciences 2026 stock outlook: WAKIX narcolepsy revenue tracking above $1 billion, pipeline expansion, single-product concentration, orexin competition, generic timing, peers, and US tax angles for investors.
MDU Resources stock outlook for 2026. After spinning off Knife River and Everus, MDU is a regulated electric, gas and pipeline business. Here is the rate-base math, the regulatory and funding risks, peers, and how US investors should size it.
O-I Glass (OI) stock outlook for 2026: after a guidance cut sent shares near their 52-week low, we break down the Fit to Win restructuring, soft European volumes, furnace economics, leverage, peers and what to watch each quarter.
TNL (Travel + Leisure) stock outlook for 2026: how the timeshare model makes money, the Club Wyndham and RCI moat, free cash flow and buybacks, consumer loan receivables, leverage risk, peers, and US tax angles.
NSIT (Insight Enterprises) 2026 stock outlook: how a low-margin hardware reseller is shifting toward cloud, services and AI deployments, why gross profit matters more than revenue, peer comparison with CDW, and US tax and metrics to watch.
Macerich (MAC) stock outlook for 2026: how the Path Forward deleveraging plan and improving occupancy set up a re-rating case, why leverage still caps it, how to read FFO and REIT dividends, and what to watch each quarter.
AESI Atlas Energy Solutions stock outlook for 2026: the Permian in-basin proppant position, the Dune Express conveyor moat, frac sand price deflation, drilling-activity swings, peer comparison and tax scenarios for US investors.
RHI (Robert Half) 2026 stock outlook: how white-collar staffing and Protiviti consulting make money, what a hiring-cycle turn would do to earnings, the AI disruption risk, peer comparison, and US tax scenarios for investors.
RARE (Ultragenyx Pharmaceutical) stock outlook for 2026: a rare-disease and gene therapy biotech down 57% in a year, with Crysvita cash flow, binary trial readouts, dilution risk and a US-investor playbook for sizing and taxes.
Bio-Techne (TECH) stock outlook for 2026: the reagent and Simple Western moat, the bet on a biopharma R&D spending rebound, the growth-stall risk, a 52-week-high valuation check, peer comparison, and US tax and position-sizing scenarios.
FCNCA First Citizens BancShares 2026 stock outlook: the SVB acquisition, fading purchase accounting accretion, deposit cost normalization, family control, commercial real estate risk, peers, and tax angles for US investors.
INFY (Infosys) 2026 stock outlook. How India's large IT services ADR earns money, whether GenAI and large-deal TCV can offset soft discretionary IT spend, rupee and dollar effects, and how it stacks up against TCS, Wipro, Accenture and Cognizant.
HIW (Highwoods Properties) 2026 stock outlook: a Sunbelt office REIT concentrated in best business districts. Occupancy, FFO and AFFO coverage of the dividend, rate and vacancy risk, and how it stacks up against Cousins and peers.
PLXS (Plexus Corp) 2026 stock outlook. How high-mix contract manufacturing for medical, aerospace and defense, and industrial customers earns sticky margins, how it stacks up against FLEX, JBL, SANM and CLS, and where the demand cycle can bite.
VAL (Valaris) 2026 stock outlook: the largest offshore driller by fleet, how floater day-rates and contract backlog drive earnings, the ARO joint venture, peer comparison with RIG, NE and SDRL, and oil-cycle risk.